Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
53 /100
HIGH RISK
Score updated Oct 13, 2026

JBIO — Jade Biosciences, Inc. Dilution Risk Tracker

Track JBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track JBIO — Get alerts when the score changes →

As of October 13, 2026, Jade Biosciences, Inc. (JBIO) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. Jade Biosciences, Inc. has a market capitalization of $890.36M, 63.60M shares outstanding, 122 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
40
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
🔁 Convertible Conversion model 15%
• Convertible debt present: 10.7% potential dilution
🔔 Track JBIO — Get forecast alerts →

Market Data

Market Cap$890.36M
Shares Outstanding63.60M
Float32.74M
Cash$461.20M
Debt$849.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore53/100DilutionWatch score record
Shares Outstanding63.60MVerified float table or market cache
Public Float32.74MVerified float table or market cache
Market Cap$890.36MMarket data cache
Cash Runway97.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 23.5% shares (2026Q1 vs prior)
122 institutional holders · 58.64M shares
#1 FMR LLC 7.09M shares
#2 JANUS HENDERSON GROUP PLC 6.21M shares
#3 Fairmount Funds Management LLC 4.55M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.12M
Days to Cover11.3
% of Float37.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-06
xbrl XBRL CONVERTIBLE 2026-03-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual JBIO Dilution Snapshot

Jade Biosciences, Inc. (JBIO) has a DilutionScore of 53/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

JBIO's DilutionScore is currently 53/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 49/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202653/100HIGH53 days
Jul 17 – Aug 21, 202649/100MEDIUM35 days
Jul 16, 202648/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

JBIO shares outstanding have increased 0.1% from 49.31M (Mar 2026) to 49.36M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 10, 202649.36M32.73M▲ 0.09%
May 02, 202649.35M32.70M▲ 0.04%
Apr 21, 202649.32M32.69M▲ 0.80%
Mar 11, 202649.31M32.43M▲ 3.89%
Mar 09, 202649.31M31.22M▲ 6.04%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track JBIO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment JBIO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking JBIO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for JBIO
JBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.